The News Courier in Athens, Alabama

May 25, 2013

Drug maker recalls meds in 13 states


Associated Press

— MONTGOMERY, Ala. (AP) — The Alabama Department of Public Health is working with other health agencies to investigate an injectable anti-inflammatory drug prepared by a compounding manufacturer in Tennessee.

Main Street Family Pharmacy of Newbern, Tenn. shipped the tainted medicine to clinics in 13 states, including to one clinic in Alabama.

The investigation began after the U.S. Food and Drug Administration was notified of seven people who developed infections or adverse reactions after receiving injections of methylprednisolone acetate (MPA). It's the same drug that was linked to last year's deadly outbreak of fungal meningitis.

The investigation is in an early stage and is rapidly evolving, according to Dr. Mary McIntyre of the ADPH.

The Alabama clinic will begin notifying patients to ask them to report any signs and symptoms of complications.